|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/32 | |
| A61P 35/00 |
| (11) | Number of the document | 3191527 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15759788.1 |
| Date of filing the European patent application | 2015-09-04 | |
| (97) | Date of publication of the European application | 2017-07-19 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/070285 |
| Date | 2015-09-04 |
| (87) | Number | WO 2016/037947 |
| Date | 2016-03-17 |
| (30) | Number | Date | Country code |
| 14184201 | 2014-09-10 | EP | |
| 201462095912 P | 2014-12-23 | US |
| (72) |
MALIK, Sebastian, DE
REUSCH, Dietmar, DE
SCHNUERIGER, Alfred, CH
TEJADA, Max L., US
THOMANN, Marco, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | GALACTOENGINEERED IMMUNOGLOBULIN 1 ANTIBODIES |
| GALACTOENGINEERED IMMUNOGLOBULIN 1 ANTIBODIES |